Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.34 |
| ▸ | PPARA | Q07869 | 11/20 | 0.34 |
| ▸ | PPARD | Q03181 | 4/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13334938 | 0.93 | L3MBTL1 (0.42) | L3MBTL1ALDH1A1 | |
| SCHEMBL13334552 | 0.89 | MC4R (0.34) | PPARGPPARAPPARDALDH1A1GPR119 | |
| SCHEMBL3356445 | 0.85 | L3MBTL1 (0.44) | L3MBTL1ALDH1A1 | |
| SCHEMBL3355480 | 0.84 | ALDH1A1 (0.45) | L3MBTL1ALDH1A1 | |
| SCHEMBL3358660 | 0.83 | MC4R (0.35) | ALDH1A1GPR119MGLL | |
| SCHEMBL3353490 | 0.82 | MC4R (0.34) | ALDH1A1GPR119MGLL | |
| SCHEMBL3359583 | 0.81 | L3MBTL1 (0.45) | L3MBTL1ALDH1A1 | |
| SCHEMBL3356313 | 0.81 | MEN1 (0.36) | L3MBTL1ALDH1A1 | |
| SCHEMBL3353800 | 0.81 | ALDH1A1 (0.37) | ALDH1A1GPR119MGLL | |
| SCHEMBL13308228 | 0.80 | MC4R (0.34) | ALDH1A1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010068881-A1 | NOVEL BENZODIOXANE AND BENZOXAZINE DERIVATIVES USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-06-17 | — | — | WO | disclosed |